Potential therapies for anaplastic lymphoma kinase-driven tumors in children: progress to date
{{output}}
Anaplastic lymphoma kinase (ALK) is an oncogenic tyrosine kinase that is deregulated due to a variety of molecular mechanisms in pediatric cancer. They include chromosomal translocations, activation mutations, and gene amplifications. Since the initial discove... ...